$Evaluating the antifracture efficacy of bisphosphonates.$

Evaluating the antifracture efficacy of bisphosphonates.

Oral bisphosphonate dosing schedules have evolved from the original daily regimens to weekly (alendronate and risedronate) and monthly (risedronate and ibandronate) regimens. Intravenous (i.v.) bisphosphonates are administered less frequently-quarterly ibandronate injection and yearly zoledronic aci...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Pazianas, M, Epstein, S, Zaidi, M
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	2009

Παρόμοια τεκμήρια

Antifracture agents for prostate cancer patients on androgen deprivation therapy
ανά: Bhupendra P Singh, κ.ά.
Έκδοση: (2010-01-01)

The sequential antifracturative treatment: a meta-analysis of randomized clinical trials
ανά: Angelo Fassio, κ.ά.
Έκδοση: (2024-04-01)

Safety of bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2011)

Bisphosphonates and bone quality.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2014)

Atrial fibrillation and bisphosphonate therapy.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2010)

Potential therapeutic effects of oral bisphosphonates on the intestine.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2011)

Safety issues with bisphosphonate therapy for osteoporosis.
ανά: Suresh, E, κ.ά.
Έκδοση: (2014)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
ανά: Pazianas, M
Έκδοση: (2013)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
ανά: Alexander J Rodríguez, κ.ά.
Έκδοση: (2022-06-01)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
ανά: Alexander J Rodríguez, κ.ά.
Έκδοση: (2021-07-01)

Bisphosphonates and colon cancer: reply.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Bisphosphonates and colon cancer: Reply
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
ανά: Pazianas M, κ.ά.
Έκδοση: (2013-10-01)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
ανά: Michael Pazianas
Έκδοση: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2011)

Atrial fibrillation and the use of oral bisphosphonates
ανά: Michael Pazianas, κ.ά.
Έκδοση: (2011-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2010)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
ανά: Abrahamsen, B, κ.ά.
Έκδοση: (2013)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
ανά: Pazianas, M, κ.ά.
Έκδοση: (2010)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2014)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
ανά: Pazianas, M, κ.ά.
Έκδοση: (2008)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2007)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
ανά: Garriga, C, κ.ά.
Έκδοση: (2018)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
ανά: Garriga, C, κ.ά.
Έκδοση: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
ανά: Garriga, C, κ.ά.
Έκδοση: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
ανά: Garriga, C, κ.ά.
Έκδοση: (2017)

Bisphosphonates
ανά: Bishop, N, κ.ά.
Έκδοση: (2013)

Bisphosphonates
ανά: Fırat Öztürk
Έκδοση: (2009-04-01)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
ανά: Russell, R, κ.ά.
Έκδοση: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
ανά: Russell, R, κ.ά.
Έκδοση: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
ανά: Sujata Sharma, κ.ά.
Έκδοση: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
ανά: İlke Coşkun Benlidayı, κ.ά.
Έκδοση: (2015-08-01)

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
ανά: Russell, R, κ.ά.
Έκδοση: (2008)

Bisphosphonates: An update
ανά: Nalliappan Ganapathy, κ.ά.
Έκδοση: (2012-01-01)

Bisphosphonates 2006
ανά: Russell, R
Έκδοση: (2006)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
ανά: Pazianas, M, κ.ά.
Έκδοση: (2012)